Stevanato Group S.p.A (STVN) Cash from Operations Growth (3y) (2023 - 2026)
Stevanato Group S.p.A (STVN) Cash from Operations Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 16.81% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 53.64% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 70.05% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -9.84% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -33.35% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 13.75% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -8.92% |
| 10 | Stevanato Group S.p.A | 5.39 Bn | 5.25 Bn | 88.01 Mn | 30.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.44% |
| Dec 31, 2025 | 21.61% |
| Sep 30, 2025 | 154.08% |
| Jun 30, 2025 | 4.12% |
| Mar 31, 2025 | 162.86% |
| Dec 31, 2024 | -9.75% |
| Sep 30, 2024 | -1.62% |
| Jun 30, 2024 | -28.30% |
| Mar 31, 2024 | 121.92% |
| Dec 31, 2023 | -46.73% |
| Sep 30, 2023 | -14.59% |
| Jun 30, 2023 | -23.51% |